Peptide Linkers for Polypeptide Compositions and Methods for Using Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 61/449,225, filed Mar 4, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,580,922 | Peptide Linkers for Polypeptide Compositions and Methods for Using Same In force · High confidence | Shire Human Genetic Therapies, Inc. | In force | High confidence | ||
| US 11,065,307 | Therapeutic Fusion Protein Comprising an Alpha-N-Acetylglucosaminidase and a Lysosomal Targeting Moiety In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | ||
| US 9,206,235 | Peptide Linkers for Polypeptide Compositions and Methods for Using Same In force · Medium confidence | Shire Human Genetic Therapies, Inc. | In force | Medium confidence | ||
| US 9,814,764 | Treatment of Sanfilippo Syndrome Type B by Intrathecal Administration of Alpha-N-Acetylglucosaminidase In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | ||
| US 9,932,568 | Peptide Linkers for Polypeptide Compositions and Methods for Using Same In force · High confidence | Shire Human Genetic Therapies, Inc. | In force | High confidence | ||
| Application 13/168,969 | Treatment of Sanfilippo Syndrome Type B Abandoned Abandoned Jun 18, 2013 | Shire Human Genetic Therapies, Inc. | Abandoned | Abandoned Jun 18, 2013 | ||
| Application 17/350,909 | Treatment of Sanfilippo Syndrome Type B Abandoned Abandoned Feb 4, 2025 | Takeda Pharmaceutical Company Limited | Abandoned | Abandoned Feb 4, 2025 |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Shire LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.